ArticleEuropean spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society2025
Comparison of three frailty evaluation tools in predicting postoperative adverse events in older patients undergoing lumbar fusion surgery: a prospective cohort study of 240 patients.
Article in European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Leveraging automated machine learning to benchmark, deconstruct, and compare frailty indices for predicting adverse spinal surgery outcomes.Scientific reports · 2026Article
- The Impact of Frailty Indices on Predicting Complications and Functional Recovery in Proximal Humerus Fractures: A Comparative Study.Medicina (Kaunas, Lithuania) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
purposeTo compare the utility of the frailty phenotype (FP), the FRAIL scale, and 5-item modified Frailty Index (mFI-5) in predicting postoperative adverse events after enhanced recovery after lumbar fusion surgery in older patients.
methodsThis study prospectively included older patients (> 75 years) who underwent transforaminal lumbar interbody fusion from June 2019 to August 2021. Frailty status was evaluated using FP, the FRAIL scale, and mFI-5. The study investigated the associations between these three frailty tools and total adverse events, complications, and secondary outcomes. Multivariable logistic regression analysis was performed to identify predictors of total adverse events, complications, and secondary outcomes.
resultsCorrelation analysis demonstrated that frailty assessed by the FP was significantly associated with an increased incidence of complications (55.7% vs. 41.5%, p =.028) and prolonged hospital stays (29.5% vs. 16.9%, p =.021). Frailty identified using the FRAIL scale was significantly linked to prolonged hospital stays (33.7% vs. 16.2%, p =.002). Additionally, frailty assessed by the mFI-5 was associated with higher rates of 30-day readmission (18.5% vs. 6.3%, p =.003) and 30-day reoperation (7.4% vs. 0.6%, p =.007). Multivariate logistic regression revealed that an FP score of ≥ 3 was an independent risk factor for total adverse events, complications, and secondary outcomes, while a FRAIL score of ≥ 3 was an independent risk factor for secondary outcomes.
conclusionFrailty as defined by the FP is an independent risk factor for total adverse events, complications, and secondary outcomes. Frailty as defined by the FRAIL scale is an independent risk factor for secondary outcomes. The mFI-5 has not been demonstrated to be an independent risk factor for any postoperative adverse events.
Indexed as
Identifiers
40053079What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.